Radiopharmaceutical Theranostics Market, Global Outlook and Forecast 2022-2028
![](/report_cover/11201/radiopharmaceutical-theranostics-market-global-outlook-n-forecast-2022-2028_en.gif)
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
This report contains market size and forecasts of Radiopharmaceutical Theranostics in Global, including the following market information:
Global Radiopharmaceutical Theranostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Radiopharmaceutical Theranostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radiopharmaceutical Theranostics include Nihon Medi-Physics, ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceutical Theranostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceutical Theranostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Radiopharmaceutical Theranostics Market Segment Percentages, by Type, 2021 (%)
Global Radiopharmaceutical Theranostics Market Segment Percentages, by Application, 2021 (%)
Global Radiopharmaceutical Theranostics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceutical Theranostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Radiopharmaceutical Theranostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Radiopharmaceutical Theranostics in Global, including the following market information:
Global Radiopharmaceutical Theranostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Radiopharmaceutical Theranostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radiopharmaceutical Theranostics include Nihon Medi-Physics, ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceutical Theranostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceutical Theranostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Radiopharmaceutical Theranostics Market Segment Percentages, by Type, 2021 (%)
- Oncology
- Cardiology
- Others
Global Radiopharmaceutical Theranostics Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Academic & Research Institutes
- Others
Global Radiopharmaceutical Theranostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceutical Theranostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Radiopharmaceutical Theranostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Nihon Medi-Physics
- ITM Isotopen Technologien M?nchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- GE Healthcare
- Theragnostics Ltd.
- NuView Life Sciences
- Jubilant Pharma Limited
- Lantheus Holdings, Inc.
- Curium Pharma
- Bayer AG
- Clarity Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Radiopharmaceutical Theranostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Theranostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RADIOPHARMACEUTICAL THERANOSTICS OVERALL MARKET SIZE
2.1 Global Radiopharmaceutical Theranostics Market Size: 2021 VS 2028
2.2 Global Radiopharmaceutical Theranostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Radiopharmaceutical Theranostics Players in Global Market
3.2 Top Global Radiopharmaceutical Theranostics Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Theranostics Revenue by Companies
3.4 Top 3 and Top 5 Radiopharmaceutical Theranostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Radiopharmaceutical Theranostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Theranostics Players in Global Market
3.6.1 List of Global Tier 1 Radiopharmaceutical Theranostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Theranostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Radiopharmaceutical Theranostics Market Size Markets, 2021 & 2028
4.1.2 Oncology
4.1.3 Cardiology
4.1.4 Others
4.2 By Type - Global Radiopharmaceutical Theranostics Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
4.2.2 By Type - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
4.2.3 By Type - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Radiopharmaceutical Theranostics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Academic & Research Institutes
5.1.4 Others
5.2 By Application - Global Radiopharmaceutical Theranostics Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
5.2.2 By Application - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
5.2.3 By Application - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Radiopharmaceutical Theranostics Market Size, 2021 & 2028
6.2 By Region - Global Radiopharmaceutical Theranostics Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
6.2.2 By Region - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
6.2.3 By Region - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Radiopharmaceutical Theranostics Revenue, 2017-2028
6.3.2 US Radiopharmaceutical Theranostics Market Size, 2017-2028
6.3.3 Canada Radiopharmaceutical Theranostics Market Size, 2017-2028
6.3.4 Mexico Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Radiopharmaceutical Theranostics Revenue, 2017-2028
6.4.2 Germany Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.3 France Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.4 U.K. Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.5 Italy Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.6 Russia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.7 Nordic Countries Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.8 Benelux Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Radiopharmaceutical Theranostics Revenue, 2017-2028
6.5.2 China Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.3 Japan Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.4 South Korea Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.5 Southeast Asia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.6 India Radiopharmaceutical Theranostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Radiopharmaceutical Theranostics Revenue, 2017-2028
6.6.2 Brazil Radiopharmaceutical Theranostics Market Size, 2017-2028
6.6.3 Argentina Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue, 2017-2028
6.7.2 Turkey Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.3 Israel Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.4 Saudi Arabia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.5 UAE Radiopharmaceutical Theranostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Nihon Medi-Physics
7.1.1 Nihon Medi-Physics Corporate Summary
7.1.2 Nihon Medi-Physics Business Overview
7.1.3 Nihon Medi-Physics Radiopharmaceutical Theranostics Major Product Offerings
7.1.4 Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.1.5 Nihon Medi-Physics Key News
7.2 ITM Isotopen Technologien M?nchen AG
7.2.1 ITM Isotopen Technologien M?nchen AG Corporate Summary
7.2.2 ITM Isotopen Technologien M?nchen AG Business Overview
7.2.3 ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Major Product Offerings
7.2.4 ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.2.5 ITM Isotopen Technologien M?nchen AG Key News
7.3 Advanced Accelerator Applications
7.3.1 Advanced Accelerator Applications Corporate Summary
7.3.2 Advanced Accelerator Applications Business Overview
7.3.3 Advanced Accelerator Applications Radiopharmaceutical Theranostics Major Product Offerings
7.3.4 Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.3.5 Advanced Accelerator Applications Key News
7.4 Telix Pharmaceuticals
7.4.1 Telix Pharmaceuticals Corporate Summary
7.4.2 Telix Pharmaceuticals Business Overview
7.4.3 Telix Pharmaceuticals Radiopharmaceutical Theranostics Major Product Offerings
7.4.4 Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.4.5 Telix Pharmaceuticals Key News
7.5 GE Healthcare
7.5.1 GE Healthcare Corporate Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Radiopharmaceutical Theranostics Major Product Offerings
7.5.4 GE Healthcare Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.5.5 GE Healthcare Key News
7.6 Theragnostics Ltd.
7.6.1 Theragnostics Ltd. Corporate Summary
7.6.2 Theragnostics Ltd. Business Overview
7.6.3 Theragnostics Ltd. Radiopharmaceutical Theranostics Major Product Offerings
7.6.4 Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.6.5 Theragnostics Ltd. Key News
7.7 NuView Life Sciences
7.7.1 NuView Life Sciences Corporate Summary
7.7.2 NuView Life Sciences Business Overview
7.7.3 NuView Life Sciences Radiopharmaceutical Theranostics Major Product Offerings
7.7.4 NuView Life Sciences Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.7.5 NuView Life Sciences Key News
7.8 Jubilant Pharma Limited
7.8.1 Jubilant Pharma Limited Corporate Summary
7.8.2 Jubilant Pharma Limited Business Overview
7.8.3 Jubilant Pharma Limited Radiopharmaceutical Theranostics Major Product Offerings
7.8.4 Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.8.5 Jubilant Pharma Limited Key News
7.9 Lantheus Holdings, Inc.
7.9.1 Lantheus Holdings, Inc. Corporate Summary
7.9.2 Lantheus Holdings, Inc. Business Overview
7.9.3 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Major Product Offerings
7.9.4 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.9.5 Lantheus Holdings, Inc. Key News
7.10 Curium Pharma
7.10.1 Curium Pharma Corporate Summary
7.10.2 Curium Pharma Business Overview
7.10.3 Curium Pharma Radiopharmaceutical Theranostics Major Product Offerings
7.10.4 Curium Pharma Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.10.5 Curium Pharma Key News
7.11 Bayer AG
7.11.1 Bayer AG Corporate Summary
7.11.2 Bayer AG Business Overview
7.11.3 Bayer AG Radiopharmaceutical Theranostics Major Product Offerings
7.11.4 Bayer AG Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.11.5 Bayer AG Key News
7.12 Clarity Pharmaceuticals
7.12.1 Clarity Pharmaceuticals Corporate Summary
7.12.2 Clarity Pharmaceuticals Business Overview
7.12.3 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Major Product Offerings
7.12.4 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.12.5 Clarity Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Radiopharmaceutical Theranostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Theranostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RADIOPHARMACEUTICAL THERANOSTICS OVERALL MARKET SIZE
2.1 Global Radiopharmaceutical Theranostics Market Size: 2021 VS 2028
2.2 Global Radiopharmaceutical Theranostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Radiopharmaceutical Theranostics Players in Global Market
3.2 Top Global Radiopharmaceutical Theranostics Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Theranostics Revenue by Companies
3.4 Top 3 and Top 5 Radiopharmaceutical Theranostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Radiopharmaceutical Theranostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Theranostics Players in Global Market
3.6.1 List of Global Tier 1 Radiopharmaceutical Theranostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Theranostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Radiopharmaceutical Theranostics Market Size Markets, 2021 & 2028
4.1.2 Oncology
4.1.3 Cardiology
4.1.4 Others
4.2 By Type - Global Radiopharmaceutical Theranostics Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
4.2.2 By Type - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
4.2.3 By Type - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Radiopharmaceutical Theranostics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Academic & Research Institutes
5.1.4 Others
5.2 By Application - Global Radiopharmaceutical Theranostics Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
5.2.2 By Application - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
5.2.3 By Application - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Radiopharmaceutical Theranostics Market Size, 2021 & 2028
6.2 By Region - Global Radiopharmaceutical Theranostics Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
6.2.2 By Region - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
6.2.3 By Region - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Radiopharmaceutical Theranostics Revenue, 2017-2028
6.3.2 US Radiopharmaceutical Theranostics Market Size, 2017-2028
6.3.3 Canada Radiopharmaceutical Theranostics Market Size, 2017-2028
6.3.4 Mexico Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Radiopharmaceutical Theranostics Revenue, 2017-2028
6.4.2 Germany Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.3 France Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.4 U.K. Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.5 Italy Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.6 Russia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.7 Nordic Countries Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.8 Benelux Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Radiopharmaceutical Theranostics Revenue, 2017-2028
6.5.2 China Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.3 Japan Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.4 South Korea Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.5 Southeast Asia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.6 India Radiopharmaceutical Theranostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Radiopharmaceutical Theranostics Revenue, 2017-2028
6.6.2 Brazil Radiopharmaceutical Theranostics Market Size, 2017-2028
6.6.3 Argentina Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue, 2017-2028
6.7.2 Turkey Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.3 Israel Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.4 Saudi Arabia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.5 UAE Radiopharmaceutical Theranostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Nihon Medi-Physics
7.1.1 Nihon Medi-Physics Corporate Summary
7.1.2 Nihon Medi-Physics Business Overview
7.1.3 Nihon Medi-Physics Radiopharmaceutical Theranostics Major Product Offerings
7.1.4 Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.1.5 Nihon Medi-Physics Key News
7.2 ITM Isotopen Technologien M?nchen AG
7.2.1 ITM Isotopen Technologien M?nchen AG Corporate Summary
7.2.2 ITM Isotopen Technologien M?nchen AG Business Overview
7.2.3 ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Major Product Offerings
7.2.4 ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.2.5 ITM Isotopen Technologien M?nchen AG Key News
7.3 Advanced Accelerator Applications
7.3.1 Advanced Accelerator Applications Corporate Summary
7.3.2 Advanced Accelerator Applications Business Overview
7.3.3 Advanced Accelerator Applications Radiopharmaceutical Theranostics Major Product Offerings
7.3.4 Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.3.5 Advanced Accelerator Applications Key News
7.4 Telix Pharmaceuticals
7.4.1 Telix Pharmaceuticals Corporate Summary
7.4.2 Telix Pharmaceuticals Business Overview
7.4.3 Telix Pharmaceuticals Radiopharmaceutical Theranostics Major Product Offerings
7.4.4 Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.4.5 Telix Pharmaceuticals Key News
7.5 GE Healthcare
7.5.1 GE Healthcare Corporate Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Radiopharmaceutical Theranostics Major Product Offerings
7.5.4 GE Healthcare Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.5.5 GE Healthcare Key News
7.6 Theragnostics Ltd.
7.6.1 Theragnostics Ltd. Corporate Summary
7.6.2 Theragnostics Ltd. Business Overview
7.6.3 Theragnostics Ltd. Radiopharmaceutical Theranostics Major Product Offerings
7.6.4 Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.6.5 Theragnostics Ltd. Key News
7.7 NuView Life Sciences
7.7.1 NuView Life Sciences Corporate Summary
7.7.2 NuView Life Sciences Business Overview
7.7.3 NuView Life Sciences Radiopharmaceutical Theranostics Major Product Offerings
7.7.4 NuView Life Sciences Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.7.5 NuView Life Sciences Key News
7.8 Jubilant Pharma Limited
7.8.1 Jubilant Pharma Limited Corporate Summary
7.8.2 Jubilant Pharma Limited Business Overview
7.8.3 Jubilant Pharma Limited Radiopharmaceutical Theranostics Major Product Offerings
7.8.4 Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.8.5 Jubilant Pharma Limited Key News
7.9 Lantheus Holdings, Inc.
7.9.1 Lantheus Holdings, Inc. Corporate Summary
7.9.2 Lantheus Holdings, Inc. Business Overview
7.9.3 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Major Product Offerings
7.9.4 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.9.5 Lantheus Holdings, Inc. Key News
7.10 Curium Pharma
7.10.1 Curium Pharma Corporate Summary
7.10.2 Curium Pharma Business Overview
7.10.3 Curium Pharma Radiopharmaceutical Theranostics Major Product Offerings
7.10.4 Curium Pharma Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.10.5 Curium Pharma Key News
7.11 Bayer AG
7.11.1 Bayer AG Corporate Summary
7.11.2 Bayer AG Business Overview
7.11.3 Bayer AG Radiopharmaceutical Theranostics Major Product Offerings
7.11.4 Bayer AG Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.11.5 Bayer AG Key News
7.12 Clarity Pharmaceuticals
7.12.1 Clarity Pharmaceuticals Corporate Summary
7.12.2 Clarity Pharmaceuticals Business Overview
7.12.3 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Major Product Offerings
7.12.4 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.12.5 Clarity Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Radiopharmaceutical Theranostics Market Opportunities & Trends in Global Market
Table 2. Radiopharmaceutical Theranostics Market Drivers in Global Market
Table 3. Radiopharmaceutical Theranostics Market Restraints in Global Market
Table 4. Key Players of Radiopharmaceutical Theranostics in Global Market
Table 5. Top Radiopharmaceutical Theranostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Radiopharmaceutical Theranostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Radiopharmaceutical Theranostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Radiopharmaceutical Theranostics Product Type
Table 9. List of Global Tier 1 Radiopharmaceutical Theranostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceutical Theranostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Radiopharmaceutical Theranostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Radiopharmaceutical Theranostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 30. Nihon Medi-Physics Corporate Summary
Table 31. Nihon Medi-Physics Radiopharmaceutical Theranostics Product Offerings
Table 32. Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 33. ITM Isotopen Technologien M?nchen AG Corporate Summary
Table 34. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Product Offerings
Table 35. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 36. Advanced Accelerator Applications Corporate Summary
Table 37. Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Offerings
Table 38. Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 39. Telix Pharmaceuticals Corporate Summary
Table 40. Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Offerings
Table 41. Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 42. GE Healthcare Corporate Summary
Table 43. GE Healthcare Radiopharmaceutical Theranostics Product Offerings
Table 44. GE Healthcare Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 45. Theragnostics Ltd. Corporate Summary
Table 46. Theragnostics Ltd. Radiopharmaceutical Theranostics Product Offerings
Table 47. Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 48. NuView Life Sciences Corporate Summary
Table 49. NuView Life Sciences Radiopharmaceutical Theranostics Product Offerings
Table 50. NuView Life Sciences Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 51. Jubilant Pharma Limited Corporate Summary
Table 52. Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Offerings
Table 53. Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 54. Lantheus Holdings, Inc. Corporate Summary
Table 55. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Product Offerings
Table 56. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 57. Curium Pharma Corporate Summary
Table 58. Curium Pharma Radiopharmaceutical Theranostics Product Offerings
Table 59. Curium Pharma Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 60. Bayer AG Corporate Summary
Table 61. Bayer AG Radiopharmaceutical Theranostics Product Offerings
Table 62. Bayer AG Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 63. Clarity Pharmaceuticals Corporate Summary
Table 64. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Offerings
Table 65. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 1. Radiopharmaceutical Theranostics Market Opportunities & Trends in Global Market
Table 2. Radiopharmaceutical Theranostics Market Drivers in Global Market
Table 3. Radiopharmaceutical Theranostics Market Restraints in Global Market
Table 4. Key Players of Radiopharmaceutical Theranostics in Global Market
Table 5. Top Radiopharmaceutical Theranostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Radiopharmaceutical Theranostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Radiopharmaceutical Theranostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Radiopharmaceutical Theranostics Product Type
Table 9. List of Global Tier 1 Radiopharmaceutical Theranostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceutical Theranostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Radiopharmaceutical Theranostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Radiopharmaceutical Theranostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Radiopharmaceutical Theranostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2023-2028
Table 30. Nihon Medi-Physics Corporate Summary
Table 31. Nihon Medi-Physics Radiopharmaceutical Theranostics Product Offerings
Table 32. Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 33. ITM Isotopen Technologien M?nchen AG Corporate Summary
Table 34. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Product Offerings
Table 35. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 36. Advanced Accelerator Applications Corporate Summary
Table 37. Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Offerings
Table 38. Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 39. Telix Pharmaceuticals Corporate Summary
Table 40. Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Offerings
Table 41. Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 42. GE Healthcare Corporate Summary
Table 43. GE Healthcare Radiopharmaceutical Theranostics Product Offerings
Table 44. GE Healthcare Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 45. Theragnostics Ltd. Corporate Summary
Table 46. Theragnostics Ltd. Radiopharmaceutical Theranostics Product Offerings
Table 47. Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 48. NuView Life Sciences Corporate Summary
Table 49. NuView Life Sciences Radiopharmaceutical Theranostics Product Offerings
Table 50. NuView Life Sciences Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 51. Jubilant Pharma Limited Corporate Summary
Table 52. Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Offerings
Table 53. Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 54. Lantheus Holdings, Inc. Corporate Summary
Table 55. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Product Offerings
Table 56. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 57. Curium Pharma Corporate Summary
Table 58. Curium Pharma Radiopharmaceutical Theranostics Product Offerings
Table 59. Curium Pharma Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 60. Bayer AG Corporate Summary
Table 61. Bayer AG Radiopharmaceutical Theranostics Product Offerings
Table 62. Bayer AG Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
Table 63. Clarity Pharmaceuticals Corporate Summary
Table 64. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Offerings
Table 65. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Radiopharmaceutical Theranostics Segment by Type in 2021
Figure 2. Radiopharmaceutical Theranostics Segment by Application in 2021
Figure 3. Global Radiopharmaceutical Theranostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceutical Theranostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Radiopharmaceutical Theranostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radiopharmaceutical Theranostics Revenue in 2021
Figure 8. By Type - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 12. US Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 16. Germany Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 24. China Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 30. Brazil Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 33. Turkey Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 37. Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GE Healthcare Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NuView Life Sciences Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Curium Pharma Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer AG Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Radiopharmaceutical Theranostics Segment by Type in 2021
Figure 2. Radiopharmaceutical Theranostics Segment by Application in 2021
Figure 3. Global Radiopharmaceutical Theranostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceutical Theranostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Radiopharmaceutical Theranostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radiopharmaceutical Theranostics Revenue in 2021
Figure 8. By Type - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 12. US Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 16. Germany Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 24. China Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 30. Brazil Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
Figure 33. Turkey Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Radiopharmaceutical Theranostics Revenue, (US$, Mn), 2017-2028
Figure 37. Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GE Healthcare Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NuView Life Sciences Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Curium Pharma Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer AG Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)